General Information of This Metabolic Reaction (MR) (ID: MR001511)
Formula Reactant Levonorgestrel Product 16beta-hydroxylevonorgestrel
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001514 Levonorgestrel . Unclear Levonorgestrel [1]
MR001510 Levonorgestrel 3alpha, 5beta-tetrahydrolevonorgestrel Unclear Levonorgestrel [2]
MR001512 Levonorgestrel Glucuronide conjugates of levonorgestrel Conjugation - Glucuronidation Levonorgestrel [2]
MR001513 Levonorgestrel Sulfate conjugates of levonorgestrel Conjugation - Sulfation Levonorgestrel [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR001509 16beta-hydroxylevonorgestrel 16beta-hydroxylevonorgestrel glucuronide Conjugation - Glucuronidation Levonorgestrel [2]
References
1 [Influence of CYP3A4/5 polymorphisms in the pharmacokinetics of levonorgestrel: a pilot study]. Biomedica. 2012 Oct-Dec;32(4):570-7.
2 DrugBank(Pharmacology-Metabolism)Levonorgestrel

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.